stockrow
Friday 6 November 2026
Export COGT’s income statement to Excel — free account
Cogent Biosciences, Inc.
COGT Healthcare Biotechnology
- EPS
- +1.89%
- Free cash flow
- −42.0%
Quarter to June 2026, against a year earlier
31.60
2.02
+6.83%
Follow COGT
Alert me
Cogent Biosciences, Inc. (COGT) Operating cash flow
Cogent Biosciences, Inc.'s operating cash flow for fiscal 2025 was −$264.4M, compared with −$207.8M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$307.5M. Over the past ten years it has ranged from −$264.4M (fiscal 2025) to $17.7M (fiscal 2015) — the current reading is the lowest in ten years. Operating cash flow has fallen for 5 consecutive fiscal years. Cogent Biosciences, Inc. ranks 570th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$264.4M | — |
| FY2024 | −$207.8M | — |
| FY2023 | −$153.6M | — |
| FY2022 | −$118.6M | — |
| FY2021 | −$58.8M | — |
| FY2020 | −$35.9M | — |
| FY2019 | −$41.5M | — |
| FY2018 | −$32.5M | — |
| FY2017 | −$25.8M | — |
| FY2016 | −$18.6M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | −$77.3M | — |
| Mar 2026 | −$86.9M | — |
| Dec 2025 | −$79.1M | — |
| Sep 2025 | −$64.3M | — |
| 36 more quarters | Free account |
Against its own ten years
Low −$264.4M
High $17.7M
Ten-year median
−$41.5M
Current reading's percentile
9
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| TVTX Travere Therapeutics, Inc. compare | $176.6M |
| PTCT PTC Therapeutics, Inc. compare | $10.5M |
| ERAS Erasca, Inc. compare | −$98.0M |
| MANE Veradermics Incorporated compare | −$122.9M |
| KOD Kodiak Sciences Inc. compare | −$158.5M |
| DNTH Dianthus Therapeutics, Inc. compare | −$175.2M |
| SRRK Scholar Rock Holding Corporation compare | −$296.8M |
| COGT Cogent Biosciences, Inc. | −$307.5M |
| CRSP CRISPR Therapeutics AG compare | −$374.6M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on COGT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement